What Clinical Efficacy Can Medical Aesthetic Clinics Expect When Using Excimer Laser Equipment For Hypopigmented Scars And Striae Distensae, And How Can Results Be Optimized?

Excimer laser treatment can produce clinically meaningful repigmentation in both hypopigmented scars and striae albae. In reported protocols, approximately 80% of patients show visible darkening within nine or fewer sessions, with average appearance improvement of about 61% for hypopigmented scars and 68% for striae albae. Results are optimized through conservative dose escalation, consistent treatment frequency, and careful monitoring of the erythematous endpoint.

The excimer laser is most effective when treatment is delivered to the target lesion—not surrounding normal skin—with the dose adjusted to maintain controlled erythema without excessive inflammation. Clinics should present the expected outcome as meaningful lightening reduction or repigmentation, not guaranteed complete color restoration.

What Clinical Efficacy Can Clinics Expect?

Hypopigmented scars

Excimer treatment stimulates melanocyte activity in the basal cell layer, supporting the repigmentation of areas that appear lighter than the surrounding skin.

Clinical results summarized in the primary evidence indicate approximately 61% average improvement in the appearance of hypopigmented scars. Visible darkening may occur relatively early, with about 80% of patients responding within nine or fewer treatments.

Striae albae

Striae albae are mature, pale stretch marks in which the altered dermal structure and reduced pigmentation make treatment more challenging than for early red striae.

Excimer treatment can produce approximately 68% average appearance improvement in striae albae under reported protocols. The improvement refers to visible blending and darkening of the lesion, rather than complete removal of the stretch mark’s structural changes.

Expected treatment course

A typical course consists of two treatments per week for approximately 10 to 15 sessions. Some patients may show darkening sooner, while others require most or all of the planned course before the response becomes clinically apparent.

The treatment timeline should therefore be assessed progressively rather than judged after only one or two sessions.

How the Excimer Laser Produces Repigmentation

Targeted melanocyte stimulation

The primary therapeutic objective is to stimulate an increase in the number and size of melanocytes in the basal cell layer.

As pigment production increases, the treated scar or striae can gradually become closer in color to the surrounding skin.

Selective lesion treatment

Excimer equipment delivers treatment to a defined area, allowing the clinician to focus energy on the hypopigmented lesion while limiting exposure of normally pigmented skin.

This targeted approach is particularly useful when the lesion has irregular borders or is located near areas where unnecessary UV exposure should be minimized.

Pigment improvement does not equal scar removal

Excimer treatment primarily addresses the color contrast between the lesion and surrounding skin.

It does not, by itself, correct every component of a scar or striae distensae, such as textural irregularity, dermal atrophy, or fibrotic change.

Optimizing the Treatment Protocol

Start at a controlled erythema-producing dose

Protocols commonly begin at the patient’s minimal erythema dose, or MED, or approximately 50 mJ/cm² below MED.

The dose is then escalated as needed to maintain the intended erythematous response. The objective is controlled, treatment-related erythema—not excessive inflammation or injury.

Maintain consistent treatment frequency

A twice-weekly schedule is commonly used over a 10- to 15-session course.

Consistent spacing helps clinicians evaluate whether the skin is responding and allows dose adjustments based on the observed reaction between sessions.

Adjust treatment to the individual response

Dose selection should not be treated as a fixed setting for every patient or every body site.

Clinicians should assess the degree and duration of erythema, the patient’s skin type, lesion location, prior treatment history, and any signs of unwanted pigment alteration before increasing energy.

Document progress objectively

Standardized photographs taken under consistent lighting and positioning are important because gradual pigment blending can be difficult to judge subjectively.

Useful assessments include:

Baseline and follow-up photographs.
Session number and delivered dose.
Erythema response after treatment.
Degree of repigmentation or color blending.
Any hyperpigmentation, irritation, or delayed reaction.

Treat scars and striae as different indications

Although both conditions may respond through melanocyte stimulation, they should not automatically be treated as identical.

Hypopigmented scars may have a history of resurfacing, trauma, inflammation, or deeper tissue alteration. Striae albae also contain dermal structural changes that may remain even when color improves.

Using Combination Strategies Appropriately

Do not transfer vitiligo evidence directly

The primary reference reports stronger results for vitiligo when excimer treatment is combined with twice-daily topical tacrolimus.

In that setting, the proportion achieving more than 75% repigmentation increased from 50% to 77% in UV-sensitive regions and from 20% to 60% in UV-resistant regions.

These figures support the concept that topical adjuncts can enhance repigmentation in selected conditions, but they should not be presented as direct efficacy data for hypopigmented scars or striae without indication-specific evidence and clinical oversight.

Address residual texture separately

If a scar has substantial textural or fibrotic change, pigment treatment alone may leave an unsatisfactory result.

Fractional resurfacing approaches may be considered when the clinical goal includes scar remodeling, but combining procedures requires careful sequencing, appropriate patient selection, and control of inflammation and pigmentary risk.

Consider the original cause of hypopigmentation

Post-resurfacing hypopigmentation may reflect melanocyte injury associated with excessive treatment depth.

For selected cases, supplementary evidence describes fractionated 1,550-nm erbium laser treatment combined with topical agents such as bimatoprost and tretinoin or pimecrolimus, producing more than 50% improvement in reported hypopigmented areas. This is a separate strategy and should not be confused with the standard excimer protocol.

Understanding the Trade-offs

Improvement is usually gradual and incomplete

The reported averages represent meaningful clinical improvement, not universal clearance.

Some lesions will respond less well, particularly when the hypopigmentation is extensive, longstanding, structurally deep, or associated with significant scarring.

Pigment response and texture response are different outcomes

A lesion may become less conspicuous because its color improves while its surface irregularity remains.

Clinics should define success before treatment: pigment blending, overall visibility, texture, or a combination of these outcomes.

Excessive dosing can undermine the objective

Pursuing faster darkening by escalating too aggressively increases the risk of excessive inflammation and unwanted pigmentary change.

The safer principle is to increase treatment only when the observed response and interval examination support it.

Body site affects practical expectations

The visibility of improvement depends on the contrast between the lesion and surrounding skin, the lesion’s age, and its anatomical location.

Patients should understand that a favorable average response does not guarantee uniform repigmentation across every treated area.

Results should not be overpromised as permanent

The cited data establish treatment response during the reported treatment courses, but they do not establish that every result will remain unchanged indefinitely.

Long-term follow-up, recurrence, and the need for additional treatment should be discussed conservatively rather than assumed.

How to Apply This to Your Clinic

A sound program combines realistic patient selection with individualized dosing and objective follow-up.

If your primary focus is hypopigmented scars: Present excimer treatment as a targeted repigmentation method with approximately 61% average appearance improvement in reported protocols, while separately evaluating whether textural scar remodeling is also required.
If your primary focus is striae albae: Set expectations around approximately 68% average appearance improvement and explain that color blending may improve even when the underlying stretch-mark texture persists.
If your primary focus is treatment efficiency: Use a twice-weekly schedule, begin at MED or about 50 mJ/cm² below MED, and escalate only to maintain controlled erythema.
If your primary focus is safety and reproducibility: Use test treatment where appropriate, document erythema and pigment changes, photograph results consistently, and avoid treating a protocol number as a substitute for clinical assessment.
If your primary focus is combination therapy: Keep vitiligo-specific tacrolimus data separate from scar and striae outcomes, and introduce additional resurfacing or topical strategies only when they address a clearly defined secondary problem.

With disciplined dosing and realistic counseling, excimer laser treatment can provide substantial pigment blending while preserving a clinically defensible approach to safety and expectations.

Summary Table:

Indication	Average Improvement	Typical Sessions	Key Optimization Strategy
Hypopigmented scars	~61% appearance improvement	10-15 (2x/week)	Start at MED or 50 mJ/cm² below, escalate to maintain erythema, use targeted lesion treatment
Striae albae	~68% appearance improvement	10-15 (2x/week)	Same as above, but manage expectations: texture may remain; combine with resurfacing if needed

Ready to enhance your clinic's offerings with advanced excimer laser technology? At BELIS, we specialize in providing professional-grade medical aesthetic equipment exclusively for clinics and premium salons. Our portfolio includes advanced laser systems, IPL, PDT, HIFU, body sculpting, and more. Contact us today to learn how our excimer lasers can help you achieve superior patient outcomes and grow your practice. Contact us now!